The Cavalier Daily - University of Virginia's Student Newspaper

Amanda Talalaj

U.Va. clinical trials precede FDA emergency use authorization of convalescent plasma as COVID-19 treatment

By Amanda Talalaj | September 10, 2020

U.S. Food and Drug Administration announced convalescent plasma as an emergency-use authorization treatment for COVID-19, but since May 5 of this year, trials on this method of treatment have already been conducted at the University.

Studying neutrino properties is important in explaining why the universe and its particles look and behave in the way they do.

U.Va. physicists explore subatomic questions in multi-million dollar, international experiments

By Amanda Talalaj | November 20, 2019

Through the FermiLab experiments, the field of particle physics — which concerns itself with studying the most minute components of matter and their interaction — is likely to undergo major sources of discovery.

Amanda Talalaj

U.Va. clinical trials precede FDA emergency use authorization of convalescent plasma as COVID-19 treatment

U.Va. physicists explore subatomic questions in multi-million dollar, international experiments

More articles »

Faculty Senate discusses future of college athletics after NCAA reforms

The Cavalier Daily elects editors for its 136th term

Elijah Saunders can guide Virginia to victory

EDITORIAL: Reckon consistently with our history

No. 8 field hockey falls short versus No. 2 Northwestern in NCAA quarterfinals

This Thanksgiving, Virginia fans have a lot to be thankful for

Around the world in three stories — recommendations from Language House residents

Men’s basketball unravels late in blowout loss to No. 11 Tennessee

The ‘Batten Curve’ — what’s the big deal?

One win away from bowl game eligibility, football hosts No. 13 Southern Methodist

Print Edition